Call for Abstracts - VPH Research to Business Session

8-9 September 2010, Barcelona, Spain.
The vision of the Virtual Physiological Human is a grand challenge. A key feature of the VPH initiative is the promise of some low-hanging fruits, applications where the power of multiscale simulation technology can be placed into clinical and industrial practices in the not-so-distant future. Viewed in this light, it is essential for all VPH projects to actively disseminate their research results towards the biomedical industry.

For the second year, the VPH Network of Excellence is organising a two-day meeting where the VPH community showcases its best results to the biomedical industry. This is not only to increase the exploitation potential of VPH research, but also to expand the take-on of VPH technologies in the health industry.

This year the program revolves around three types of sessions:

  • Research to Business (R2B), where research consortia present to industry delegates the best results they achieved;
  • Business to Business (B2B), where small and large companies, as well as university spin-offs present products and services that other companies can use to develop other products and services for the final end-user.
  • Regulatory to Business (G2B), where experts of regulatory affair will report on the position of simulation technologies with respect to regulatory affairs.

VPH research projects are invited to participate in this event in three ways:

  • Ensuring that industrial partners of your consortia are informed of the event and are motivated to send delegates
  • Explore with their industrial partners or spin-offs the interest to present their products and services at the B2B session. Those interested should contact Elena Villalba Mora, This email address is being protected from spambots. You need JavaScript enabled to view it..
  • Submit an abstract of the presentation on the best research results they would like to showcase in the R2B session.

Selection Criteria
The draft programme consists of 12 slots of 30-minutes for each presentation. In the event that abstracts received are more than the number of available slots, the organisation of the event will make a selection according to the following criteria:

  • Fair representation of all projects (if two abstracts come from the same project one might be excluded)
  • Broadest possible coverage of the clinical and industrial domains
  • Closeness of results to be presented to the industrial/clinical exploitation

Consortia and research groups who wish to present, should follow the instructions below.

Submission of Abstracts
Your abstract must reach the event organisers no later than the 23rd of April 2010. Selected contributions will be invited for presentation during the 8th and 9th of September 2010.

Instructions for Submission of Abstracts
Please send your abstract to Vanessa Diaz, This email address is being protected from spambots. You need JavaScript enabled to view it. Abstracts will be between 350 and 500 words long, without including the title and the authors. The format is free; feel free to include illustrations.

Abstract Contents
Abstracts should cover the following topics:

  • Subject of research
  • Clinical and/or industrial translation
  • Clinical uptake
  • Development of tools if any

Evaluation
The event organisers will evaluate all abstracts. Notification of acceptance will be provided the last week of April.

For further information, please visit:
http://www.vph-noe.eu

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

  • Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
  • Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
  • Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
  • Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
  • Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
  • Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Finally, by involving clinical and industrial stakeholders, VPH NoE also plans to lay a reliable ground to support sustainable interactions and collaboration between research and healthcare communities.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...